Stock Research: Raffles Medical Group

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Raffles Medical Group

SGX:BSL SG1CH4000003
70
  • Value
    22
  • Growth
    77
  • Safety
    Safety
    33
  • Combined
    27
  • Sentiment
    96
  • 360° View
    360° View
    70
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Raffles Medical Group Ltd is a Singapore-based integrated private healthcare provider. It operates in Healthcare Services, Hospital Services, and Investment Holdings. The company has facilities in Singapore, China, Japan, Vietnam, and Cambodia. In the last fiscal year, the company had a market cap of $1,481 million, profits of $478 million, revenue of $551 million, and 2,989 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 70 (better than 70% compared with alternatives), overall professional sentiment and financial characteristics for the stock Raffles Medical Group are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Raffles Medical Group. The consolidated Growth Rank has a good rank of 77, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 77% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 96, which means that professional investors are more optimistic about the stock than for 96% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 33, which means that the share price of Raffles Medical Group is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 67% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 22, which means that the company has a financing structure that is riskier than those of 78% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
33 49 41 43
Growth
77 1 1 87
Safety
Safety
22 20 32 28
Sentiment
96 47 86 94
360° View
360° View
70 10 15 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
91 30 37 51
Opinions Change
50 50 50 50
Pro Holdings
n/a 27 79 90
Market Pulse
95 94 93 100
Sentiment
96 47 86 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
33 49 41 43
Growth
77 1 1 87
Safety Safety
22 20 32 28
Combined
27 4 4 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
28 34 34 25
Price vs. Earnings (P/E)
37 43 37 41
Price vs. Book (P/B)
38 54 37 49
Dividend Yield
72 85 78 54
Value
33 49 41 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
57 11 8 52
Profit Growth
51 12 10 44
Capital Growth
67 27 37 69
Stock Returns
73 9 11 93
Growth
77 1 1 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
47 45 66 50
Refinancing
23 26 24 22
Liquidity
35 33 42 29
Safety Safety
22 20 32 28

Similar Stocks

Discover high‑ranked alternatives to Raffles Medical Group and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Genting Singapore

SGX:G13
Country: Singapore
Industry: Casinos & Gaming
Size: Medium
Full Stock Analysis

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

UOL Group

SGX:U14
Country: Singapore
Industry: Real Estate: Diversified Operations
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.